APP and Alzheimer disease: In agreement with previous studies performed in the APP/PS1 mouse model of AD14, our data revealed a stage-dependent synaptic proteostasis impairment in the OB during AD pathogenesis, where more than 50% of the differential proteome across AD phenotypes tends to localize to synaptic ending.